Related Experiment Videos
Differences in the tumor-associated reactivity of blood lymphocytes and tumor-draining lymph node cells in sarcoma
Journal of the National Cancer Institute
|July 1, 1973
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Mixed venous oxygen saturation is a prognostic marker after surgery for aortic stenosis.
Acta anaesthesiologica Scandinavica·2010
A multicenter initial clinical experience with right heart support and beating heart coronary surgery.
The heart surgery forum·2001
Neurological injury after surgery for ischemic heart disease: risk factors, outcome and role of metabolic interventions.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2001
21-Gene recurrence score assay in pN2-3 Early-Stage breast cancer: a national cancer database study.
Journal of the National Cancer Institute·2026
Projected impact of population-level multi-cancer early detection screening: a discrete event simulation analysis.
Journal of the National Cancer Institute·2026
Late effects after novel therapies for childhood cancer: Anticipating the future landscape of health outcomes for survivors.
Journal of the National Cancer Institute·2026
Hysterectomy-corrected incidence of cervical cancer among women with HIV in the United States, 2001-2019.
Journal of the National Cancer Institute·2026
Markers of cervical intraepithelial neoplasia grade 2 regression and subsequent risk of CIN3.
Journal of the National Cancer Institute·2026
An artificial intelligence algorithm characterizes the deterioration of body composition from systemic therapy for patients with advanced prostate cancer.
Journal of the National Cancer Institute·2026
Associations between endoscopic findings and clinicopathological characteristics in primary gastrointestinal lymphoma: a single-center retrospective study.
Scandinavian journal of gastroenterology·2026
Targeting IKZF2 with molecular glue degraders for cancer immunotherapy.
Drug discovery today·2026